Literature DB >> 14551261

Repression of p65 transcriptional activation by the glucocorticoid receptor in the absence of receptor-coactivator interactions.

Jun Wu1, Yu Li, Jessica Dietz, Deepak S Lala.   

Abstract

Glucocorticoids are among the most potent antiinflammatory agents, acting through the glucocorticoid receptor (GR) to suppress gene expression of a variety of cytokines. This appears to be via transcriptional interference (or transrepression) of key regulatory factors such as nuclear factor-kappaB and activator protein 1. Ligand-bound GR can also activate gene transcription (transactivation) via direct binding to glucocorticoid response elements. Transactivation by GR is potentiated by accessory coactivators such as steroid receptor coactivator 1 and peroxisome proliferator-activated receptor gamma coactivator 1, whereas the role of these proteins in transrepression is unclear.Here, we show that GR can recruit several coactivator receptor interacting domains in a ligand-dependent manner. All interactions require the charge clamp defined by K579/E755, while a subset also requires a second charge clamp defined by R585/D590, within the GR ligand-binding domain. A point mutation, E755A, abolished all GR-receptor interacting domain interactions and led to a decrease in GR-mediated transactivation, but did not significantly affect GR-mediated transrepression of Gal4-p65 activity. Overexpression of a GR-interacting coactivator peptide blocked transactivation but did not affect transrepression of p65 or TNFalpha-induced IL-6 promoter activity. Finally, the GR antagonist RU486 did not recruit coactivators to GR but maintained the ability to transrepress p65 activity. Our data suggest that different coactivators utilize distinct contact points to interact with GR. Although GR interactions with specific coactivators are critical for transactivation, they appear to be dispensable for at least certain aspects of GR-mediated transrepression of nuclear factor-kappaB. This is consistent with the notion that all GR- mediated repression is not intrinsically linked to activation and can be separated mechanistically.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14551261     DOI: 10.1210/me.2002-0373

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  9 in total

Review 1.  General molecular biology and architecture of nuclear receptors.

Authors:  Michal Pawlak; Philippe Lefebvre; Bart Staels
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

2.  Strain differences in the effects of chronic corticosterone exposure in the hippocampus.

Authors:  G E Hodes; B R Brookshire; T E Hill-Smith; S L Teegarden; O Berton; I Lucki
Journal:  Neuroscience       Date:  2012-06-23       Impact factor: 3.590

3.  Hormone binding and co-regulator binding to the glucocorticoid receptor are allosterically coupled.

Authors:  Samuel J Pfaff; Robert J Fletterick
Journal:  J Biol Chem       Date:  2010-03-24       Impact factor: 5.157

Review 4.  Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

Authors:  Ilse M E Beck; Wim Vanden Berghe; Linda Vermeulen; Keith R Yamamoto; Guy Haegeman; Karolien De Bosscher
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

5.  Doubling the size of the glucocorticoid receptor ligand binding pocket by deacylcortivazol.

Authors:  Kelly Suino-Powell; Yong Xu; Chenghai Zhang; Yong-Guang Tao; W David Tolbert; S Stoney Simons; H Eric Xu
Journal:  Mol Cell Biol       Date:  2007-12-26       Impact factor: 4.272

6.  Glucocorticoids suppress T cell function by up-regulating microRNA-98.

Authors:  Trevor E Davis; Katalin Kis-Toth; Attila Szanto; George C Tsokos
Journal:  Arthritis Rheum       Date:  2013-07

Review 7.  Fighting the Fire: Mechanisms of Inflammatory Gene Regulation by the Glucocorticoid Receptor.

Authors:  Laura Escoter-Torres; Giorgio Caratti; Aikaterini Mechtidou; Jan Tuckermann; Nina Henriette Uhlenhaut; Sabine Vettorazzi
Journal:  Front Immunol       Date:  2019-08-07       Impact factor: 7.561

8.  Org 214007-0: a novel non-steroidal selective glucocorticoid receptor modulator with full anti-inflammatory properties and improved therapeutic index.

Authors:  Marie-José C van Lierop; Wynand Alkema; Anke J Laskewitz; Rein Dijkema; Hans M van der Maaden; Martin J Smit; Ralf Plate; Paolo G M Conti; Christan G J M Jans; C Marco Timmers; Constant A A van Boeckel; Scott J Lusher; Ross McGuire; Rene C van Schaik; Jacob de Vlieg; Ruben L Smeets; Claudia L Hofstra; Annemieke M H Boots; Marcel van Duin; Benno A Ingelse; Willem G E J Schoonen; Aldo Grefhorst; Theo H van Dijk; Folkert Kuipers; Wim H A Dokter
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

9.  Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas.

Authors:  Kimberly S Butler; William C Hines; Christopher M Heaphy; Jeffrey K Griffith
Journal:  Cancer Med       Date:  2012-07-24       Impact factor: 4.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.